Complete financial analysis of Check-Cap Ltd. (CHEK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Check-Cap Ltd., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
You may be interested
- Assicurazioni Generali S.p.A. (G.MI) Income Statement Analysis – Financial Results
- Khaitan Chemicals and Fertilizers Limited (KHAICHEM.NS) Income Statement Analysis – Financial Results
- Teladan Group Berhad (0230.KL) Income Statement Analysis – Financial Results
- I-Hwa Industrial Co.,Ltd (1456.TW) Income Statement Analysis – Financial Results
- Haiwan International Development Co., Ltd (3252.TWO) Income Statement Analysis – Financial Results
Check-Cap Ltd. (CHEK)
About Check-Cap Ltd.
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 244.00K | 173.00K | -788.00K | 0.00 | 0.00 |
| Cost of Revenue | 212.00K | 405.00K | 205.00K | 148.00K | 115.00K | 148.00K | 157.00K | 130.00K | 92.00K | 0.00 | 0.00 | 0.00 |
| Gross Profit | -212.00K | -405.00K | -205.00K | -148.00K | -115.00K | -148.00K | -157.00K | 114.00K | 81.00K | -788.00K | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 46.72% | 46.82% | 100.00% | 0.00% | 0.00% |
| Research & Development | 8.29M | 14.27M | 12.35M | 10.01M | 10.47M | 7.62M | 6.84M | 5.49M | 5.84M | 3.11M | 2.66M | 2.69M |
| General & Administrative | 9.55M | 5.76M | 4.97M | 3.92M | 3.60M | 3.45M | 3.16M | 3.56M | 6.62M | 1.70M | 1.08M | 1.20M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.00K | 7.00K | 0.00 | 0.00 | 0.00 |
| SG&A | 9.55M | 5.76M | 4.97M | 3.92M | 3.60M | 3.45M | 3.16M | 3.57M | 6.63M | 1.70M | 1.08M | 1.20M |
| Other Expenses | 1.44M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 275.00K | 7.00K | 7.00K |
| Operating Expenses | 19.29M | 20.03M | 17.32M | 13.93M | 14.07M | 11.06M | 10.00M | 9.06M | 12.46M | 4.81M | 3.75M | 3.90M |
| Cost & Expenses | 19.29M | 20.03M | 17.32M | 13.93M | 14.07M | 11.06M | 10.00M | 9.06M | 12.46M | 4.81M | 3.75M | 3.90M |
| Interest Income | 1.77M | 926.00K | 119.00K | 69.00K | 245.00K | 243.00K | 66.00K | 139.00K | 61.00K | 10.00K | 59.00K | 183.00K |
| Interest Expense | 13.00K | 12.00K | 13.00K | 12.00K | 8.00K | 7.00K | 7.00K | 7.00K | 47.00K | 5.00K | 0.00 | 6.00K |
| Depreciation & Amortization | 212.00K | 405.00K | 205.00K | 148.00K | 115.00K | 148.00K | 157.00K | 130.00K | 92.00K | 78.00K | 77.00K | 73.00K |
| EBITDA | -17.65M | -18.69M | -16.98M | -13.69M | -13.95M | -10.44M | -9.84M | -8.93M | -12.23M | -4.46M | -3.90M | -3.84K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3,660.66% | -7,150.87% | 506.73% | 0.00% | 0.00% |
| Operating Income | -19.29M | -20.03M | -17.32M | -13.93M | -14.07M | -11.06M | -10.00M | -9.06M | -12.46M | -4.81M | -3.74M | -3.91M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3,713.93% | -7,204.05% | 610.41% | 0.00% | 0.00% |
| Total Other Income/Expenses | 1.72M | 926.00K | 119.00K | 86.00K | 233.00K | 473.00K | 236.00K | 244.00K | 173.00K | 3.93M | 604.00K | 187.00K |
| Income Before Tax | -17.57M | -19.11M | -17.20M | -13.85M | -13.84M | -10.59M | -9.77M | -8.82M | -12.29M | -4.08M | -4.00M | -3.72M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3,613.93% | -7,104.05% | 517.26% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 146.00K | -110.00K | -85.00K | -240.00K | -1.00K | 6.00K | 8.00K | 0.00 | 734.00K | 243.00K | 6.00K |
| Net Income | -17.57M | -19.25M | -17.09M | -13.76M | -13.60M | -10.59M | -9.77M | -8.83M | -12.29M | -4.08M | -4.00M | -3.72M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3,617.21% | -7,104.05% | 517.26% | 0.00% | 0.00% |
| EPS | -3.00 | -3.39 | -4.13 | -9.07 | -34.05 | -52.19 | -134.31 | -146.10 | -247.49 | -82.10 | -160.71 | -149.69 |
| EPS Diluted | -3.00 | -3.39 | -4.13 | -9.07 | -34.05 | -52.19 | -134.31 | -146.10 | -247.49 | -82.10 | -160.71 | -149.69 |
| Weighted Avg Shares Out | 5.85M | 5.67M | 4.14M | 1.52M | 399.30K | 202.90K | 72.75K | 60.41K | 49.66K | 49.64K | 24.86K | 24.86K |
| Weighted Avg Shares Out (Dil) | 5.85M | 5.67M | 4.14M | 1.52M | 399.30K | 202.90K | 72.75K | 60.41K | 49.66K | 49.64K | 24.86K | 24.86K |
Why Is Check-Cap (CHEK) Stock Up 44% Today?
Check-Cap (NASDAQ: CHEK ) stock is on the rise Tuesday as the clinical stage medical diagnostics company announces a business combination with Nobul AI . This deal will have Check-Cap hand of the reigns of the company to Nobul AI's leadership...
Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement
Proposed business combination to create a North American technology company with an AI-driven fintech marketplace. Combined company to apply for listing on Nasdaq and TSX TORONTO , March 25, 2024 /PRNewswire/ -- Nobul AI Corp. ("Nobul") and Check-Cap Ltd.
SYMETRYX COMMENTS ON SUCCESSFUL CAMPAIGN AT CHECK-CAP LTD
TORONTO , Dec. 22, 2023 /PRNewswire/ - Symetryx Corporation ("Symetryx"), a Canadian venture company, is pleased to announce that the shareholders of Check-Cap Ltd. (NASDAQ: CHEK) voted overwhelmingly to elect all the director nominees proposed by Symetryx at the Annual...
CHECK- CAP BOARD MEMBER'S STATEMENT ON THE STAND SUGGESTS A POTENTIAL CONFLICT OF INTEREST WITH KEYSTONE DENTAL
SYMETRYX RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER SYMETRYX RECOMMENDS VOTING FOR THEIR QUALIFIED INDEPENDENT BOARD NOMINEES TIME IS SHORT - THE VOTE DEADLINE IS 11:59 pm EST THURSDAY DECEMBER 14 th 2023 - SHAREHOLDERS MAY VOTE OR CHANGE A...
CITING THE MANY FDA ADVERSE EFFECTS TO KEYSTONE DENTAL - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER ALSO RECOMMENDS VOTING FOR THE SYMETRYX BOARD NOMINEES
TORONTO , Dec. 8, 2023 /PRNewswire/ - Further to its news release of November 28, 2023, Symetryx continues to urge its fellow Check-Cap Ltd. ("Check-Cap") (NASDAQ: CHEK) shareholders to VOTE AGAINST the Keystone Dental and FOR the Symetryx slate of...
CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER AND FOR THE SYMETRYX BOARD OF DIRECTORS NOMINEES
TORONTO , Dec. 5, 2023 /PRNewswire/ - Today, Symetryx Corporation ("Symetryx") once again encourages our fellow shareholders of Check-Cap Ltd. ("Check-Cap") (NASDAQ: CHEK) to review the news release issued by Yoav Kimchy, PhD, the Founder and former Chief Technology Officer,...
Symetryx Today Issues Open Letter to Shareholders In Regard to the Upcoming Annual General Meeting
Recommends Fellow Shareholders Vote AGAINST Keystone Transaction & the Check-Cap Board Nominees - Further Recommends a Vote FOR the Symetryx Slate of Director Candidates Cites Unrealistic and Aggressive Valuation of Keystone Used to Justify the Merger and Troubling Cash Burn...
Keystone Dental Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
Q3 revenue increased 18.9% year-over-year to $16.8M, including $11.9M from the U.S. Check-Cap shareholders to vote on proposed Business Combination Agreement with Keystone Dental at Annual General Meeting on Monday, December 18th, 2023 IRVINE, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE)...
Check-Cap Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
Check-Cap shareholders to vote on proposed Business Combination Agreement with Keystone Dental at Annual General Meeting on Monday, December 18 th ISFIYA, Israel , Nov. 27, 2023 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), today announced financial...
Keystone Dental Holdings and Check-Cap Ltd Enter into Definitive Business Combination Agreement
Proposed business combination to create a Nasdaq-listed medical device company focused on advancing the commercial execution and market development of Keystone's comprehensive portfolio of implants, arches and other tooth replacement solutions
Source: https://incomestatements.info
Category: Stock Reports